Bacteriophage therapy for infections in cancer patients

Clinical and Applied Immunology Reviews

Volumn 1, Issue 3-4, 2001, Pages 131-134

  Weber Dabrowska, B ^a   Mulczyk, M ^a   Gorski A ^a  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Bacteriophage; Cancer; Infections

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; BACTERIOPHAGE; BACTERIUM ISOLATE; DECUBITUS; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNE DEFICIENCY; INFECTION SENSITIVITY; MENINGITIS; NONHUMAN; PNEUMONIA; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; REVIEW; SEPTICEMIA; SKIN INFECTION; SOLID TUMOR; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0010321950     PISSN: 15291049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1529-1049(01)00015-0     Document Type: Review

References (9)

1. Duckworth DH. Bacteriophages. In: Granoff A, Webster RG, editors. Encyclopedia of virology, Academic Press 1999;725-30.
2. P. Das Bacteriophage therapy offers new hope for streptococcal infections Lancet 357 2001 938
3. R.M. Carlton Phage therapy past history and future prospects Arch Immun Ther Exp 47 1999 267-274
4. M.S. Glimore J.A. Hoch A vancomycin surprise Nature 399 1999 524-526
5. K. Sieradzki R.B. Roberts S.W. Haber A. Tomasz The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection New Eng J Med 340 1999 517-523
6. T.L. Smith M.L. Pearson K.R. Wilcox Emergence of vancomycin resistance in Staphylococcus aureus New Eng J Med 340 1999 493-501
7. A. Pirisi Phage therapy-advantages over antibiotics? Lancet 356 2000 1418
8. S. Slopek I. Durlakowa B. Weber-Dabrowska A. Kucharewicz-Krukowska M. Dabrowski R. Bisikiewicz Results of bacteriophage treatment of suppurative bacterial infections Arch Immun Ther Exp 31 1983 267-291
9. B. Weber-Dabrowska M. Zimecki M. Mulczyk Effective phage therapy is associated with normalization of cytokine production by blood cell cultures Arch Immun Ther Exp 48 2000 31-37